ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

Human Subject Rules Now Have forces Of Law; Already Conforming

June 7, 1974

Becker, Brown Testify On Biomedical Funding, Manpower Needs

March 23, 1990

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007